GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navana Pharmaceuticals PLC (DHA:NAVANAPHAR) » Definitions » FCF Margin %

Navana Pharmaceuticals (DHA:NAVANAPHAR) FCF Margin % : 0.00% (As of . 20)


View and export this data going back to 2022. Start your Free Trial

What is Navana Pharmaceuticals FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Navana Pharmaceuticals's Free Cash Flow for the six months ended in . 20 was BDT0.00 Mil. Navana Pharmaceuticals's Revenue for the six months ended in . 20 was BDT0.00 Mil. Therefore, Navana Pharmaceuticals's FCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, Navana Pharmaceuticals's current FCF Yield % is 0.00%.

The historical rank and industry rank for Navana Pharmaceuticals's FCF Margin % or its related term are showing as below:


DHA:NAVANAPHAR's FCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.755
* Ranked among companies with meaningful FCF Margin % only.


Navana Pharmaceuticals FCF Margin % Historical Data

The historical data trend for Navana Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navana Pharmaceuticals FCF Margin % Chart

Navana Pharmaceuticals Annual Data
Trend
FCF Margin %

Navana Pharmaceuticals Semi-Annual Data
FCF Margin %

Competitive Comparison of Navana Pharmaceuticals's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Navana Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Navana Pharmaceuticals's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Navana Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Navana Pharmaceuticals's FCF Margin % falls into.


;
;

Navana Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Navana Pharmaceuticals's FCF Margin for the fiscal year that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (A: . 20 )/Revenue (A: . 20 )
=/
= %

Navana Pharmaceuticals's FCF Margin for the quarter that ended in . 20 is calculated as

FCF Margin=Free Cash Flow (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Navana Pharmaceuticals FCF Margin % Related Terms

Thank you for viewing the detailed overview of Navana Pharmaceuticals's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Navana Pharmaceuticals Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Road 4, House 99, Block B, Banani, Dhaka, BGD, 1213
Navana Pharmaceuticals PLC operates its business under two divisions namely Veterinary Division and Human Health Division. Veterinary Division manufactures and markets high-quality veterinary medicine and feed supplements for different segments including poultry, dairy and aqua products. Human Health Division operates its manufacturing facilities in strict compliance with WHO cGMP guidelines for the production of tablets, capsules, oral liquids, ampoules, dry powder vials, powder for suspension, eye drops, creams and ointments.

Navana Pharmaceuticals Headlines

No Headlines